Clinical trial
Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age
NCT01729247 is registered in ClinicalTrials.gov with Aerocrine AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age
- Lead sponsor
- Aerocrine AB
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- November 30, 2012
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.